LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

B SEOUL, South Korea, May 17, 2026 /PRNewswire/ — LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo…
posteditor
posteditor
Articles: 21727

Other News